Literature DB >> 16335199

[Clinical observation on plum-blossom needle therapy combined with cupping for treatment of acute facial paralysis].

Wei-Hong Li1.   

Abstract

OBJECTIVE: To observe clinical therapeutic effect of plum-blossom needle therapy combined with cupping at the affected side on acute facial paralysis.
METHODS: The such patients were randomly divided into a treatment group and a control group, 32 cases in each group. The patients of the two groups were treated with the same Western medicines, and at the acute stage, the treatment group were treated by tapping the affected face, the surroundings of retroanricular mastoid, the region with aching pain in the neck side with plum-blossom needle and cupping, and then local radiation by TDP, and the control group were treated by TDP radiation at the same area. In the stationary phase and restoration stage, the two groups were treated by body acupuncture at the affected side with a same therapeutic course.
RESULTS: The cured rate was 81.2% in the treatment group and 68.7% in the control group with a significant difference between the two groups (P < 0.05), and there was a significant difference between the two groups in therapeutic course for cure (P < 0.01).
CONCLUSION: Plum-blossom needle therapy combined with cupping at the affected side can help restore functions of facial nerves, and obviously increase the cured rate and shorten the therapeutic course for acute facial paralysis.

Entities:  

Mesh:

Year:  2005        PMID: 16335199

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Clinical research evidence of cupping therapy in China: a systematic literature review.

Authors:  Huijuan Cao; Mei Han; Xun Li; Shangjuan Dong; Yongmei Shang; Qian Wang; Shu Xu; Jianping Liu
Journal:  BMC Complement Altern Med       Date:  2010-11-16       Impact factor: 3.659

Review 2.  An updated review of the efficacy of cupping therapy.

Authors:  Huijuan Cao; Xun Li; Jianping Liu
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.